Description
Ulcavis (Bismuth Subcitrate) Coated Tablets 120 mg. №112
Ingredients
- Each coated tablet contains 120 mg of bismuth subcitrate.
Dosage
- The recommended dosage is one tablet to be taken orally three times a day, or as directed by a healthcare professional.
Indications
- Ulcavis tablets are indicated for the treatment of Helicobacter pylori infection and associated gastritis.
Contraindications
- Do not use Ulcavis tablets if you are allergic to bismuth subcitrate or any other ingredients in the product.
Directions
- Swallow the tablet whole with water. Do not crush or chew the tablet.
Scientific Evidence
Bismuth subcitrate, the active ingredient in Ulcavis tablets, has been extensively studied for its efficacy in treating Helicobacter pylori infections. Research has shown that bismuth subcitrate helps to eradicate the bacteria and reduce inflammation in the stomach lining, leading to improved symptoms and healing of ulcers.
Additional Information
- Ulcavis tablets have been shown to be well-tolerated with minimal side effects, making them a safe and effective option for the treatment of H. pylori infections.
- Studies suggest that bismuth subcitrate may have anti-inflammatory effects and provide mucosal protection in the gastrointestinal tract, aiding in the healing process and symptom relief for patients with gastritis and ulcers.
